Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 128
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2, Peripheral Arterial Disease Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Recruiting
  • Diabetes Mellitus, Type 2
  • Peripheral Arterial Disease
  • Birmingham, Alabama
  • +179 more
Jan 23, 2023

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +393 more
Jan 17, 2023

Diabetes, Type 2 Trial in Worldwide (Linagliptin, Empagliflozin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +82 more
Aug 23, 2022

Diabetes, Type 2 Trial in Worldwide (Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Canagliflozin 100 mg
  • +2 more
  • Little Rock, Arkansas
  • +121 more
Aug 18, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, empagliflozin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +105 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, sitagliptin, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +241 more
Jul 11, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin glargine, Insulin aspart)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +2 more
  • Concord, California
  • +82 more
Jul 7, 2022

Gut Microbiota in Chronic Noncommunicable Diseases

Completed
  • Arterial Hypertension
  • +7 more
    • Moscow, Russian Federation
    • +1 more
    Apr 18, 2022

    Diabetes, Type 2 Trial in Worldwide (Dapagliflozin, Saxagliptin, Placebo)

    Active, not recruiting
    • Diabetes Mellitus, Type 2
    • Sacramento, California
    • +122 more
    Mar 21, 2022

    Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

    Active, not recruiting
    • Diabetes Mellitus, Type 2
    • Montgomery, Alabama
    • +444 more
    Mar 11, 2022

    DIA_CENTRAL:T2D Treatment Pattern in Central Europe

    Completed
    • Diabetes Mellitus, Type 2
    • Byala, Bulgaria
    • +176 more
    Feb 18, 2022

    Heart Failure, Diastolic, Diabetes, Type 2 Trial in Moscow (Empagliflozin, Standard care)

    Completed
    • Heart Failure, Diastolic
    • Diabetes Mellitus, Type 2
    • Moscow, Russian Federation
      National Medical Research Center for Cardiology
    Jan 10, 2022

    Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin degludec)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Faster-acting insulin aspart
    • +3 more
    • Concord, California
    • +166 more
    Jan 6, 2022

    Looking at How Tresiba® Works in People With Type 2 Diabetes in

    Completed
    • Diabetes Mellitus, Type 2
    • insulin degludec
    • Alushta, Russian Federation
    • +39 more
    Aug 20, 2021

    Diabetes, Type 2, Coronary Artery Disease Trial in Worldwide (Apabetalone, Placebo, Atorvastatin)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Coronary Artery Disease
    • Bahía Blanca, Argentina
    • +213 more
    Jul 23, 2021

    Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, , metformin)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +184 more
    Jul 1, 2021

    Diabetes, Type 2, Diabetes, Type 1, Lipohypertrophy Trial in Ekaterinburg, Moscow (Optimal insulin injection)

    Completed
    • Diabetes Mellitus, Type 2
    • +2 more
    • Optimal insulin injection
    • Ekaterinburg, Russian Federation
    • +3 more
    Apr 30, 2021

    Coronary Arteriosclerosis, Diabetes, Type 2, Cerebrovascular Accident Trial in Worldwide (Atorvastatin (Lipitor))

    Completed
    • Coronary Arteriosclerosis
    • +4 more
    • Atorvastatin (Lipitor)
    • Ioannina, Greece
    • +32 more
    Feb 17, 2021

    Diabetes, Type 2, Renal Insufficiency Trial in Worldwide (vildagliptin, Placebo)

    Completed
    • Diabetes Mellitus, Type 2
    • Renal Insufficiency
    • Buenos Aires, Argentina
    • +89 more
    Dec 11, 2020

    Diabetes, Type 2 Trial in Worldwide (MEDI0382 low dose, MEDI0382 mid dose, MEDI0382 high dose)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • MEDI0382 low dose
    • +4 more
    • Birmingham, Alabama
    • +118 more
    Jul 31, 2020

    Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • insulin degludec/liraglutide
    • insulin glargine
    • Glendale, Arizona
    • +87 more
    Aug 10, 2020

    Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +231 more
    Jun 16, 2020

    Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Ticagrelor 60 mg
    • Ticagrelor placebo
    • Alexander City, Alabama
    • +1241 more
    Mar 4, 2020

    Insulin Therapy in Type 2 Diabetes

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
      • Little Rock, Arkansas
      • +152 more
      Feb 25, 2020

      Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

      Completed
      Has Results
      • Diabetes
      • Diabetes Mellitus, Type 2
      • Anniston, Alabama
      • +118 more
      Feb 14, 2020